{"tm":1686888880,"s":"REGN","news":[{"t":"Regeneron Pharmaceuticals (NASDAQ:REGN) Seems To Use Debt Quite Sensibly","dt":"Jun-15-23 07:00AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/regeneron-pharmaceuticals-nasdaq-regn-seems-110037170.html"},{"t":"15 Most Profitable Drugs In The World","dt":"Jun-13-23 06:04AM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/15-most-profitable-drugs-world-100455774.html"},{"t":"3 Biotech Stocks to Sell in June Before They Crash and Burn","dt":"Jun-06-23 09:11AM","a":"InvestorPlace","u":"https:\/\/finance.yahoo.com\/news\/3-biotech-stocks-sell-june-131123596.html"},{"t":"Updated Linvoseltamab (BCMAxCD3) Data from Pivotal Trial Demonstrates Early, Deep and Durable Responses in Patients with Heavily Pre-treated Multiple Myeloma","dt":"May-25-23 05:05PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/updated-linvoseltamab-bcmaxcd3-data-pivotal-210500089.html"},{"t":"Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained","dt":"May-22-23 01:50PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/sanofi-regeneron-highlight-dupixent-data-175054154.html"},{"t":"High School Scientists and Engineers Win Nearly $9 Million at the Regeneron International Science and Engineering Fair 2023","dt":"May-19-23 03:32PM","a":"PR Newswire","u":"https:\/\/finance.yahoo.com\/news\/high-school-scientists-engineers-win-193200771.html"},{"t":"Regeneron Announces Investor Conference Presentations","dt":"May-18-23 04:01PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/regeneron-announces-investor-conference-presentations-200100828.html"},{"t":"UPDATE 3-U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents","dt":"10:20AM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/1-u-supreme-court-rules-142002906.html"},{"t":"CEO Pay Packages Fell Sharply in 2022, the First Decline in a Decade","dt":"May-15-23 03:59PM","a":"The Wall Street Journal","u":"https:\/\/finance.yahoo.com\/m\/e1f221ff-2e60-3990-82c5-beefe2cb9d2d\/ceo-pay-packages-fell-sharply.html"},{"t":"15 Biggest Immunotherapy Companies in the World","dt":"04:09PM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/15-biggest-immunotherapy-companies-world-200959863.html"},{"t":"Analyst Report: Regeneron Pharmaceuticals, Inc.","dt":"May-05-23 05:17PM","a":"Morningstar Research","u":"https:\/\/finance.yahoo.com\/m\/a33291ec-a157-31f0-a59e-0955942301cd\/analyst-report%3A-regeneron.html"},{"t":"Regeneron Sacrifices A Breakout As Competition Hammers At Its Biggest Moneymaker","dt":"04:07PM","a":"Investor's Business Daily","u":"https:\/\/finance.yahoo.com\/m\/95ea9cbd-6351-35be-8cdc-b05e84021b56\/regeneron-sacrifices-a.html"},{"t":"Regeneron (REGN) Q1 Earnings &amp; Sales Top, Eylea Sales Decline","dt":"12:03PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/regeneron-regn-q1-earnings-sales-160304087.html"},{"t":"Regeneron (REGN) Q1 Earnings and Revenues Top Estimates","dt":"07:55AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/regeneron-regn-q1-earnings-revenues-115511014.html"},{"t":"Drug, Biotech Stocks' Q1 Earnings on May 4: REGN, ZTS &amp; More","dt":"May-03-23 11:46AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/drug-biotech-stocks-q1-earnings-154603262.html"},{"t":"These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar","dt":"09:00AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/2-medical-stocks-could-beat-130001293.html"},{"t":"Stock Charts Strategy, May 1-5: Fed Policy, April Payrolls, Apple Earnings","dt":"Apr-28-23 01:12PM","a":"Investor's Business Daily","u":"https:\/\/finance.yahoo.com\/m\/67d2e0df-c5d3-3503-9787-472c58adddaf\/stock-charts-strategy%2C-may.html"},{"t":"Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?","dt":"10:02AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/regeneron-regn-expected-beat-earnings-140202013.html"},{"t":"Unity Touts Positive Data From Diabetic Macular Edema Study, Plans Head-To-Head Study With Regeneron's Eylea","dt":"Apr-24-23 01:34PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/unity-touts-positive-data-diabetic-173452401.html"},{"t":"Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know","dt":"Apr-21-23 06:15PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/regeneron-regn-outpaces-stock-market-221510118.html"},{"t":"Regeneron Pharmaceuticals' (NASDAQ:REGN) investors will be pleased with their splendid 159% return over the last five years","dt":"Apr-18-23 10:00AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/regeneron-pharmaceuticals-nasdaq-regn-investors-140018254.html"},{"t":"Aflibercept 8 mg and EYLEA\u00ae (aflibercept) Injection Presentations at ARVO Provide New Insights into the Treatment of Serious Retinal Diseases","dt":"07:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/aflibercept-8-mg-eylea-aflibercept-110000553.html"},{"t":"12 Best Covid Treatment Stocks to Buy Today","dt":"10:51AM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/12-best-covid-treatment-stocks-145125042.html"},{"t":"Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?","dt":"Apr-07-23 12:10PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/regeneron-regn-beat-estimates-again-161004098.html"},{"t":"One Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insider reduced their stake by 26% in the previous year","dt":"07:00AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/one-regeneron-pharmaceuticals-inc-nasdaq-110021014.html"},{"t":"Regeneron (REGN) Gains But Lags Market: What You Should Know","dt":"06:15PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/regeneron-regn-gains-lags-market-221510579.html"},{"t":"Technical Assessment: Bearish in the Intermediate-Term","dt":"07:00AM","a":"Argus Research","u":"https:\/\/finance.yahoo.com\/m\/f406f645-8cbd-3a89-9ca4-18f8621b53b3\/technical-assessment%3A-bearish.html"},{"t":"Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases","dt":"07:30AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/sonoma-biotherapeutics-regeneron-announce-collaboration-113000254.html"},{"t":"UNITY Biotechnology's Wet AMD Candidate Flunks On Non-Inferiority Threshold Compared To Regeneron's Drug","dt":"01:28PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/unity-biotechnologys-wet-amd-candidate-172823820.html"},{"t":"The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly","dt":"07:41AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/zacks-analyst-blog-highlights-sanofi-114111578.html"},{"t":"Regeneron and Sanofi Look for Billions From COPD Drug","dt":"Mar-25-23 12:54PM","a":"The Wall Street Journal","u":"https:\/\/finance.yahoo.com\/m\/22e23472-7613-3d25-9743-6c8115d5c5a0\/regeneron-and-sanofi-look-for.html"},{"t":"Wall Street Has High Hopes for These 2 Nasdaq Stocks","dt":"12:02PM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/0e8e30d5-0b2d-3b7e-bb19-423fb7e79c3c\/wall-street-has-high-hopes.html"},{"t":"ETFs in Focus on Sanofi and Regeneron's COPD Drug Data","dt":"08:00AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/etfs-focus-sanofi-regenerons-copd-120012440.html"}]}